SIRT1 and diabetic kidney disease: Collectively, these findings indicate that urinary exosomal miR-217 promotes podocyte ferroptosis and DKD progression via suppression of the SIRT1/Nrf2 pathway, suggesting a potential therapeutic target for DKD.